Imation reports profits and small sales rise in third quarter
This article was originally published in Clinica
In its first results as an independent company, Imation reported a net profit of $12 million in the third quarter compared with a loss in the previous year. Sales rose 2% to $559 million at the imaging and information company which was spun off from 3M on July 1st. On October 30th, Imation shares closed at $27.63 valuing the company at more than $1,100 million.
You may also be interested in...
Trump administration effort to reduce drug prices by curtailing agency program requiring new approvals for some old products undermines FDA’s role in policing the safety of prescription drugs, experts say.
The maker of prestige-inspired cosmetics at value prices follows its TikTok viral success by teaming with Kathleen Belsten, aka Loserfruit, the second most-followed female gamer on the Amazon-owned livestreaming platform Twitch.
As distribution of Regeneron’s monoclonal antibody treatment for coronavirus begins, OWS officials worry about provider confusion with Lilly’s product due to differences in preparation and administration.